T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Unitil
UTL
$992M
| $934K | ﹤0.01% |
19,266
+5,089
| +36% | +$248K |
|
|
BRSL
2102
Brightstar Lottery PLC
BRSL
$2.15B
| $933K | ﹤0.01% |
60,210
-527
| -0.9% | -$8.59K |
|
2103
Burke & Herbert Financial Services Corp
BHRB
$1.48B
| $927K | ﹤0.01% |
14,874
+2,618
| +21% | +$164K |
|
2104
Standard Motor Products
SMP
$877M
| $927K | ﹤0.01% |
25,154
+1,749
| +7% | +$67.1K |
|
2105
Cass Information Systems
CASS
$750M
| $926K | ﹤0.01% |
22,297
+11,562
| +108% | +$471K |
|
2106
Certara
CERT
$1.24B
| $926K | ﹤0.01% |
105,076
+15,722
| +18% | +$162K |
|
2107
Select Water Solutions
WTTR
$2.73B
| $919K | ﹤0.01% |
87,356
+12,708
| +17% | +$137K |
|
|
LGN
2108
Legence Corp
LGN
$4.86B
| $918K | ﹤0.01% |
+21,326
| New | +$843K |
|
2109
National Beverage
FIZZ
$2.9B
| $915K | ﹤0.01% |
28,680
+4,749
| +20% | +$163K |
|
2110
Coursera
COUR
$1.48B
| $913K | ﹤0.01% |
124,027
-1,636,990
| -93% | -$14.3M |
|
2111
Atlas Energy Solutions
AESI
$1.47B
| $910K | ﹤0.01% |
96,584
+30,744
| +47% | +$311K |
|
2112
Ecovyst
ECVT
$1.09B
| $909K | ﹤0.01% |
93,364
+4,500
| +5% | +$39.3K |
|
|
ALX
2113
Alexander's
ALX
$1.39B
| $907K | ﹤0.01% |
4,158
+25
| +0.6% | +$5.58K |
|
2114
Sonic Automotive
SAH
$2.56B
| $905K | ﹤0.01% |
14,624
+482
| +3% | +$31.9K |
|
2115
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $902K | ﹤0.01% |
1,494
+694
| +87% | +$415K |
|
2116
Reynolds Consumer Products
REYN
$5.53B
| $901K | ﹤0.01% |
39,281
+1,703
| +5% | +$41.1K |
|
2117
Dorian LPG
LPG
$1.91B
| $898K | ﹤0.01% |
36,855
+1,508
| +4% | +$39.5K |
|
2118
Monro
MNRO
$352M
| $897K | ﹤0.01% |
44,734
+1,872
| +4% | +$34.5K |
|
2119
Edgewell Personal Care
EPC
$1.32B
| $894K | ﹤0.01% |
52,389
+4,774
| +10% | +$88.3K |
|
2120
ING
ING
$102B
| $894K | ﹤0.01% |
31,912
-955,870
| -97% | -$24.6M |
|
|
BRSP
2121
BrightSpire Capital
BRSP
$629M
| $893K | ﹤0.01% |
159,443
+6,173
| +4% | +$34K |
|
2122
Consensus Cloud Solutions
CCSI
$695M
| $890K | ﹤0.01% |
40,747
+1,342
| +3% | +$33K |
|
2123
BJ's Restaurants
BJRI
$1.48B
| $888K | ﹤0.01% |
22,532
+876
| +4% | +$31.1K |
|
2124
NextNav
NN
$3.29B
| $885K | ﹤0.01% |
53,137
+5,192
| +11% | +$73.7K |
|
2125
BlueLinx
BXC
$701M
| $882K | ﹤0.01% |
14,353
+4,606
| +47% | +$297K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.